Marissa Plescia is a reporter for MedCity News covering payers, employers and health tech. She previously worked at Becker’s Hospital Review as a finance reporter. Before that, she was a data ...

Ray Therapeutics’ gene therapy is independent of the causative genes driving inherited vision disorders, which CEO Paul Bresge says is important for reaching a broad patient population.